Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides

This study has been withdrawn prior to enrollment.
(Did not continue with development of DCCR in Very High Triglycerides)
Sponsor:
Information provided by:
Essentialis, Inc.
ClinicalTrials.gov Identifier:
NCT00973271
First received: September 5, 2009
Last updated: August 30, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)